MNOV · Medicinova Inc

The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company.

The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company.

The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company.

On January 7, 2025, the reporting person was granted an option to purchase 350,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Such performance criteria for 2025 were met, resulting in full vesting of the option.

On January 7, 2025, the reporting person was granted an option to purchase 450,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Such performance criteria for 2025 were met, resulting in full vesting of the option.

The option vests in four equal installments on September 30, 2025, December 31, 2025, March 31, 2026 and June 30,2026, subject to continued service with the Company.

The option vests in four equal installments on September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026, subject to continued service with the Company.

The option vests in four equal installments on September 30, 2025, December 31,2025, March 31,2026 and June 30,2026, subject to continued service with the Company.

The option vests in four equal installments on May 12, 2025, August 12, 2025, November 12, 2025 and February 12, 2026, subject to continued service with the Company.

The option vests over a period of one year in equal monthly installments from the 2/12/2025 date of grant.

The option vests over a period of one year in equal monthly installments from the 2/12/2025 date of grant.

The option vests in four equal installments on May 12, 2025, August 12, 2025, November 12,2025 and February 12, 2026, subject to continued service with the Company.

The option vests in four equal installments on May 12, 2025, August 12, 2025, November 12, 2025 and February 12, 2026, subject to continued service with the Company.

On January 18, 2024, the reporting person was granted an option to purchase 300,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Such performance criteria for 2024 were met, resulting in full vesting of the option.

On January 18, 2024, the reporting person was granted an option to purchase 400,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Such performance criteria for 2024 were met, resulting in full vesting of the option.

The option vests in four equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025, subject to continued service with the Company.

The option vests in four equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025, subject to continued service with the Company.

The option vests in four equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025, subject to continued service with the Company.

On February 1, 2023, the reporting person was granted an option to purchase 300,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 210,000 shares.

On February 1, 2023, the reporting person was granted an option to purchase 225,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 157,500 shares.

On February 1, 2023 the reporting person was granted an option to purchase 120,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 84,000 shares.

The option vests in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, subject to continued service with the Company.

The option vests in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, subject to continued service with the Company.

The option vests in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, subject to continued service with the Company.

On January 27, 2022 the reporting person was granted an option to purchase 81,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. Such performance criteria for 2022 were achieved at the 95% attainment level, resulting in vesting of the option as to 76,950 shares.

On January 27, 2022, the reporting person was granted an option to purchase 247,500 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. Such performance criteria for 2022 were achieved at the 95% attainment level, resulting in vesting of the option as to 235,125 shares.

On January 27, 2022, the reporting person was granted an option to purchase 157,500 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. Such performance criteria for 2022 were achieved at the 95% attainment level, resulting in vesting of the option as to 149,625 shares.

The option vests in four equal installments on September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023, subject to continued service with the Company.

The option vests in four equal installments on September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023, subject to continued service with the Company.

On February 18, 2021, the reporting person was granted an option to purchase 350,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021. Such performance criteria for 2021 were achieved at the 55% attainment level, resulting in vesting of the option as to 192,500 shares.

On February 18, 2021, the reporting person was granted an option to purchase 550,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021. Such performance criteria for 2021 were achieved at the 55% attainment level, resulting in vesting of the option as to 302,500 shares.

On February 18, 2021, the reporting person was granted an option to purchase 180,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021. Such performance criteria for 2021 were achieved at the 55% attainment level, resulting in vesting of the option as to 99,000 shares.

The option vested over a period of 4 years in equal monthly installments from the 9/1/2011 date of grant and is now fully vested.

The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested.

The option was granted on 8/3/2011, was subject to vesting based on achievement of performance criteria and vested in full on 6/14/2012.

The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested.

The option vests in four equal installments on September 30, 2021, December 31, 2021, March 31, 2022 and June 30, 2022, subject to continued service with the Company.

The option vests in four equal installments on September 30, 2021, December 31, 2021, March 31, 2022 and June 30, 2022, subject to continued service with the Company.

The option was granted on 8/3/2011, was subject to vesting based on achievement of performance criteria and vested in full on 6/14/2012.

The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested.